These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24565133)

  • 1. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
    Deep G; Jain AK; Ramteke A; Ting H; Vijendra KC; Gangar SC; Agarwal C; Agarwal R
    Mol Cancer; 2014 Feb; 13():37. PubMed ID: 24565133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells.
    Deep G; Gangar SC; Agarwal C; Agarwal R
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1222-32. PubMed ID: 21546539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifaceted impact of adipose conditioned media: Obesity-driven promotion of prostate cancer and cancer stem cell dynamics.
    Erdogan S; Serttas R; Dibirdik I; Turkekul K
    Cell Biochem Funct; 2024 Mar; 42(2):e3979. PubMed ID: 38481004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
    Li Y; Li Q; Li D; Gu J; Qian D; Qin X; Chen Y
    Life Sci; 2021 Jan; 264():118638. PubMed ID: 33164833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade.
    Mickova A; Kharaishvili G; Kurfurstova D; Gachechiladze M; Kral M; Vacek O; Pokryvkova B; Mistrik M; Soucek K; Bouchal J
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIB1 cooperates with ERα to promote epithelial mesenchymal transition in breast cancer through SNAI1 activation.
    Wang M; Zhao F; Li S; Chang AK; Jia Z; Chen Y; Xu F; Pan H; Wu H
    PLoS One; 2013; 8(6):e65556. PubMed ID: 23762395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin.
    Zhou Q; Yan B; Hu X; Li XB; Zhang J; Fang J
    Mol Cancer Ther; 2009 Jun; 8(6):1684-91. PubMed ID: 19509250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.
    Xie D; Gore C; Liu J; Pong RC; Mason R; Hao G; Long M; Kabbani W; Yu L; Zhang H; Chen H; Sun X; Boothman DA; Min W; Hsieh JT
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2485-90. PubMed ID: 20080667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin.
    Chen L; Mai W; Chen M; Hu J; Zhuo Z; Lei X; Deng L; Liu J; Yao N; Huang M; Peng Y; Ye W; Zhang D
    Pharmacol Res; 2017 Sep; 123():130-142. PubMed ID: 28712972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.
    Lan X; Lu G; Yuan C; Mao S; Jiang W; Chen Y; Jin X; Xia Q
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):177-85. PubMed ID: 26206483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
    Al-Azayzih A; Gao F; Somanath PR
    Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
    Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
    Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I collagen down-regulates E-cadherin expression by increasing PI3KCA in cancer cells.
    Cheng JC; Leung PC
    Cancer Lett; 2011 May; 304(2):107-16. PubMed ID: 21377268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells.
    López-Moncada F; Torres MJ; Lavanderos B; Cerda O; Castellón EA; Contreras HR
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.
    Wang B; Gu Y; Hui K; Huang J; Xu S; Wu S; Li L; Fan J; Wang X; Hsieh JT; He D; Wu K
    Urol Oncol; 2018 Oct; 36(10):472.e11-472.e20. PubMed ID: 30139661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.
    Putzke AP; Ventura AP; Bailey AM; Akture C; Opoku-Ansah J; Celiktaş M; Hwang MS; Darling DS; Coleman IM; Nelson PS; Nguyen HM; Corey E; Tewari M; Morrissey C; Vessella RL; Knudsen BS
    Am J Pathol; 2011 Jul; 179(1):400-10. PubMed ID: 21703419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.